MSD

MK-1308A/Lenvatinib

Biodrugs/ Drugs
Cancer
MK-1308A (Coformulated MK-1308/MK-3475), plus Lenvatinib (E7080/MK-7902) in First-line Therapy of Advanced Hepatocellular Carcinoma
2Phase II in Spain, 1Phase I